Research Projects & Grants

For Profit Organization

  • Compassionate Use of Everolimus: Individual Patient Program (IPP) for Treatment of Recurrent Progressive Clear Cell Endocervical Cancer with Everolimus, Role: Principal Investigator, Novartis Pharmaceuticals Corporation, Status: Awarded
  • (CDA) Iovance Biotherapeutics, Inc. / Dr. Yevgeniya Ioffe, Role: Principal Investigator, Iovance Biotherapeutics, Inc., Status: Awarded
  • (CDA) PDS Biotechnology Corporation / Dr. Yevgeniya Ioffe, Role: Principal Investigator, PDS Biotechnology Corporation, Status: Awarded
  • (CDA) Boehringer Ingelheim Pharmaceuticals / Dr. Niranjan Jeganathan, Role: Principal Investigator, Boehringer-Ingelheim Pharmaceuticals, Status: Awarded
  • (CDA) Ipsen Biopharmaceuticals, Inc. / Dr. Yevgeniya Ioffe, Role: Principal Investigator, Ipsen Biopharmaceuticals, Inc., Status: Awarded

Internal

  • Reversing Chemoresistance in Recurrent Ovarian Cancer, Role: PD/PI, LLU School of Medicine, (01/2022 - 12/2023) Status: Awarded
  • Improving genetic testing rates to enable targeted therapy: Novel combination therapy targeting Snail and PARP for advanced ovarian cancer in Hispanic women, Role: PD/PI, LLU School of Medicine, (01/2018 - 12/2021) Status: Awarded
  • Development of a metastatic ovarian cancer patient-derived xenograft model, Role: PD/PI, LLU School of Medicine, (01/2015 - 12/2016) Status: Closed

Non-Profit Organization

  • Improving genetic testing rates for ovarian cancer precision medicine: Combination therapy targeting Snail and PARP1 in ovarian cancer subtypes, Role: Co-PD/PI, Mary Kay Foundation, (07/2018 - 06/2020) Status: Closed

State

  • Targeting cancer stem cells to prevent recurrence and metastasis of ovarian cancer, Role: Co-Investigator, California Institute for Regenerative Medicine, (03/2018 - 02/2020) Status: Closed